Acquisitions and Preferred Stock Liability (Tables)

6 Months Ended

Jun. 30, 2022

Plasma App Ltd [Member]

Business Acquisition [Line Items]

Summary of Purchase Price Consideration

The preliminary allocation of consideration paid for the PAL acquisition is summarized as follows:

	Amount (USD)
Fair value of common stock issued (1)	$	15,290,320
Fair value of deferred consideration (2)	$	1,698,925
	$	16,989,245
Net assets of Plasma App Ltd.:
Cash and cash equivalents	$	13,822
Other assets		36,103
Intangibles		6,775,728
Goodwill		10,163,592
	$	16,989,245

(1) The fair value of the common stock issued or to be issued was determined by multiplying 9,677,419 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $1.58. We recognized $9,677 in common stock and $15,280,645 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity.

(2) The estimated fair value of the deferred consideration on acquisition date was determined by multiplying 1,075,268 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $1.58. We recognized the full amount in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity.

Optodot Corporation [Member]

Business Acquisition [Line Items]

Summary of Purchase Price Consideration

The preliminary allocation of consideration paid for the Optodot acquisition is summarized as follows:

	Amount
Fair value of unrestricted common stock issued or to be issued (1)	$	41,791,115
Fair value of restricted common stock issued (2)		8,342,152
Cash consideration		3,500,000
Total consideration	$	53,633,267
Net assets of Optodot:
Intangibles		21,453,306
Goodwill		32,179,961
	$	53,633,267

(1) The fair value of the unrestricted common stock issued or to be issued was determined by multiplying 22,348,190 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $1.87. We have issued 22,305,221 shares on the closing

date of June 22, 2022 and 42,969 shares are yet to be issued. As of June 30, 2022, we recognized $22,305 in common stock and $41,768,810 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity.

(2) The fair value of the restricted common stock issued was determined by multiplying 4,461,044 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $1.87. The restricted common stock is subject to vesting as follows:

a) Two thirds or 2,974,029 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $5,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2023 and (B) June 22, 2023;

b) One third or 1,487,015 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $10,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2024 and (B) June 22, 2024;